Doxycycline and Bismuth Subsalicylate Interaction
Drug interaction information between Doxycycline and Bismuth Subsalicylate.
Doxycycline and Bismuth Subsalicylate have a documented minor interaction in FDA labeling.
FDA drug labeling documents a minor-severity interaction between Doxycycline and Bismuth Subsalicylate. Major interactions are generally avoided, moderate ones may need monitoring or a dose adjustment, and minor ones are usually low-risk. This page shows the documented mechanism and guidance. Label-documented interactions are not a complete safety review, so always confirm your own medications with a pharmacist or doctor. Educational information, not medical advice.
How They Interact
Bismuth subsalicylate prevents your body from properly absorbing the antibiotic into your bloodstream.
What To Do
Talk to your doctor about how to time these medications so the antibiotic can be absorbed correctly.
FDA Label Information
Absorption of tetracyclines is impaired by bismuth subsalicylate.
Doxycycline Also Interacts With
- Tetracycline moderate
- Rifampin moderate
- Carbamazepine minor
- Phenytoin minor
- Doxycycline Hyclate minor
Bismuth Subsalicylate Also Interacts With
- Doxycycline Hyclate minor
- Omadacycline minor
Frequently Asked Questions
Can I take Doxycycline and Bismuth Subsalicylate together?
This is a minor interaction. Talk to your doctor about how to time these medications so the antibiotic can be absorbed correctly.
How serious is the interaction between Doxycycline and Bismuth Subsalicylate?
This interaction is classified as "minor" severity by the FDA. Minor interactions are unlikely to cause significant problems but should still be mentioned to your healthcare provider.
Why do Doxycycline and Bismuth Subsalicylate interact?
Bismuth subsalicylate prevents your body from properly absorbing the antibiotic into your bloodstream.
Understanding the Doxycycline and Bismuth Subsalicylate Interaction
FDA-approved prescribing information for these two drugs flags their combination as a minor-severity interaction. Doxycycline belongs to the Tetracycline Antibiotic class and Bismuth Subsalicylate belongs to the Antidiarrheal / Antacid class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: Bismuth subsalicylate prevents your body from properly absorbing the antibiotic into your bloodstream. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.
Context around a specific patient determines real-world impact. Doxycycline has 9 total documented interactions on file in this dataset, and Bismuth Subsalicylate has 3. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Talk to your doctor about how to time these medications so the antibiotic can be absorbed correctly. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.
An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Doxycycline or Bismuth Subsalicylate based on a web page, speak with your prescriber or pharmacist before making any change.
Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. Always consult your healthcare provider about drug interactions.
Read our methodology - how this data is sourced, computed, and verified.